NCT07437989

Brief Summary

The study involves recording personal, clinical, and instrumental information. The acquisition of the above-mentioned personal and clinical information will be carried out in conjunction with the usual follow-up visits scheduled as part of normal clinical practice. At the end of the study, a statistical analysis of the data will be carried out.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
4,000

participants targeted

Target at P75+ for all trials

Timeline
104mo left

Started Feb 2025

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress14%
Feb 2025Feb 2035

Study Start

First participant enrolled

February 23, 2025

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

February 12, 2026

Completed
15 days until next milestone

First Posted

Study publicly available on registry

February 27, 2026

Completed
8.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2035

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2035

Last Updated

February 27, 2026

Status Verified

February 1, 2026

Enrollment Period

9.9 years

First QC Date

February 12, 2026

Last Update Submit

February 20, 2026

Conditions

Keywords

ultrasoundperipheral nervous systemNeurologicalElectrodiagnosticNeuromuscolar ultrasound

Outcome Measures

Primary Outcomes (1)

  • record of all diagnosed peripheral neuropathies

    The primary objective of the study is to make a record of all diagnosed peripheral neuropathies that systematically includes and collects demographic and clinical data (including data on diagnostic methods of an electrophysiological, imaging and laboratory nature) most relevant for the diagnostic and prognostic definition of such diseases.

    through study completion, an average of 1 year

Secondary Outcomes (2)

  • assess the additional role of ultrasound in the diagnosis of diseases of the peripheral nervous system

    through study completion, an average of 1 year

  • Identifying ultrasound parameters of disease severity and/or treatment response

    through study completion, an average of 1 year

Interventions

the neurophysiological study aimed at studying the function of nerves and nerve ultrasound to evaluate its morphological appearance will be performed. Depending on the outcome of the tests carried out, further blood tests will be ordered to identify the causes of neuropathy and identify the most effective treatment where available.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

recording all diagnosed peripheral neuropathies of P. Pederzoli Hospital in order to systematically collect demographic and clinical data (including data on diagnostic methods of an electrophysiological, imaging and laboratory nature)

You may qualify if:

  • Adult patients (age ≧ 18 years old) able to give consent
  • Diagnosis of peripheral nerve disorder

You may not qualify if:

  • \. The patient is unable to consent for him/herself

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ospedale P. Pederzoli Casa di Cura Privata S.p.A.

Peschiera del Garda, Verona, 37019, Italy

RECRUITING

MeSH Terms

Conditions

Neurologic Manifestations

Condition Hierarchy (Ancestors)

Nervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 12, 2026

First Posted

February 27, 2026

Study Start

February 23, 2025

Primary Completion (Estimated)

February 1, 2035

Study Completion (Estimated)

February 1, 2035

Last Updated

February 27, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share

Locations